|
|
Blood, 1 May 2005, Vol. 105, No. 9, pp. 3583-3587.
Prepublished online as a Blood First Edition Paper on October 19, 2004; DOI 10.1182/blood-2004-08-3001.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Dendritic-cell activation by secretory phospholipase A2
Reinhold Ramoner,
Thomas Putz,
Hubert Gander,
Andrea Rahm,
Georg Bartsch,
Claudia Schaber, and
Martin Thurnher
From the Department of Urology and Kompetenzzentrum Medizin Tirol (KMT), Medical University of Innsbruck, Austria.
Dendritic cells (DCs), also referred to as the sentinels of the immune system, induce and coordinate important functions of immune surveillance. DCs acquire immunity-initiating capacity only after a process of maturation usually induced by ligands that bind to members of the tumor necrosis factor (TNF) or toll-like receptor families. Secretory phospholipase A2 (sPLA2), which hydrolyzes the sn-2 ester bond of glycerophospholipids, regulates a variety of cellular functions including migration of endothelial cells and neurite outgrowth. In the present study we investigated the role of sPLA2 in DC biology. We report that human monocyte-derived DC cultures lack sPLA2 activity but respond to exogenous sPLA2. sPLA2 alone and in cooperation with TNF- and interleukin 1  (IL-1) induced fatty acid release from DC membranes, which was accompanied by upregulation of surface markers and by an increase in the migratory and immunostimulatory capacity of the DCs. Our findings indicate that secreted enzymes such as sPLA2 can contribute to DC maturation and emphasize the role of lipid mediators in the regulation of immune responses. This observation may also have implications for DC-based vaccine development.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Bobik
Secretory phospholipase A2 type IIA: a regulator of immune function in atherosclerosis?
Cardiovasc Res,
January 1, 2009;
81(1):
9 - 10.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Ibeas, L. Fuentes, R. Martin, M. Hernandez, and M. L. Nieto
Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis
Cardiovasc Res,
January 1, 2009;
81(1):
54 - 63.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Hurley and B. A. McCormick
Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation
Infect. Immun.,
June 1, 2008;
76(6):
2259 - 2272.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N L A Misso, N Petrovic, C Grove, A Celenza, J Brooks-Wildhaber, and P J Thompson
Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration
Thorax,
January 1, 2008;
63(1):
21 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Thurnher
Lipids in dendritic cell biology: messengers, effectors, and antigens
J. Leukoc. Biol.,
January 1, 2007;
81(1):
154 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
